default author photo

Daniel Podzamczer

Bellvitge University Hospital

Catalonia

Spain

  • Bellvitge University Hospital

SCHOLARLY PAPERS

4

DOWNLOADS

333

TOTAL CITATIONS

1

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Downloads 220 (346,707)
Citation 1

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Number of pages: 31 Posted: 28 Aug 2024
Carlos Blazquez-Bondia, Francesc Català-Moll, Ferrán Torres, Christian Manzardo, Eva Bonfill, Vicenç Falcó, Pere Domingo, Daniel Podzamczer, Lluís Force, Adrià Curran, Mariona Parera, Maria Casadellà, Jose M. Miró, Marc Noguera-Julian and Roger Paredes
Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Universitat Autònoma de Barcelona (UAB), Universidad de Barcelona - Hospital Clínic Barcelona, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Infectious Disease Department, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Bellvitge University Hospital, Hospital de Mataró, Autonomous University of Barcelona - Infectious Disease Department, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, University of Barcelona - Hospital Clinic, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa and Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department
Downloads 142 (518,518)

Abstract:

Loading...

HIV, Late presentation, Microbiota, Antiretroviral therapy, dolutegravir

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Number of pages: 31 Posted: 05 Sep 2024
Carlos Blazquez-Bondia, Francesc Català-Moll, Ferrán Torres, Christian Manzardo, Eva Bonfill, Adrià Curran, Pere Domingo, Daniel Podzamczer, Lluís Force, Vicenç Falcó, Mariona Parera, Maria Casadellà, Jose M. Miró, Marc Noguera-Julian and Roger Paredes
Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Universitat Autònoma de Barcelona (UAB), Universidad de Barcelona - Hospital Clínic Barcelona, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Infectious Disease Department, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Bellvitge University Hospital, Hospital de Mataró, Autonomous University of Barcelona - Infectious Disease Department, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, University of Barcelona - Hospital Clinic, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa and Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department
Downloads 78 (826,467)
Citation 1

Abstract:

Loading...

HIV, Late presentation, microbiota, antiretroviral therapy, Dolutegravir

2.

Optimizing Anal High-Grade Squamous Intraepithelial Lesions Screening Strategies Using HPV DNA and E6/E7 mRNA Detection in Men Who Have Sex with Men Living with HIV

Number of pages: 19 Posted: 25 Sep 2023
Ana C. Silva-Klug, Sonia Paytubi, Montserrat Torres, Loris Trenti, Nuria Baixeras, Monica Sanchez-Llamas, Miquel Pavon, Silvia de Sanjose, Isabel Catalá, August Vidal, Mario Poljak, Laia Alemany, Daniel Podzamczer, Dr Sebastà Videla Cés and Maria Saumoy
Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Carlos III Health Institute, Bellvitge University Hospital, Bellvitge University Hospital, Bellvitge University Hospital, Gran Via de l'Hospitale, National Institutes of Health, ISGlobal, Bellvitge University Hospital, Bellvitge University Hospital, University of Ljubljana - Institute of Microbiology and Immunology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Bellvitge University Hospital, Bellvitge University Hospital and Bellvitge University Hospital - Department of Internal Medicine and Infectious Diseases
Downloads 62 (942,565)

Abstract:

Loading...

anal cancer screening, HSIL, HPV, High resolution anoscopy, viral biomarkers

3.

Longterm Effectiveness and Cost-Effectiveness of Anal Cancer Screening Strategies in MSM Living with HIV: A Simulation-Based Comparative Analysis of 45 Approaches Including HPV mRNA and DNA Testing

Number of pages: 27 Posted: 17 Mar 2026
Mireia Diaz, Ana C. Silva-Klug, David Gómez-Guillén, Alexandra Montoliu, Montserrat Torres, Daniel Podzamczer, Loris Trenti, Nuria Baixeras, Laia Alemany, Sonia Paytubi and Maria Saumoy
Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge Biomedical Research Institute (IDIBELL), Carlos III Health Institute, Bellvitge University Hospital, Bellvitge University Hospital, Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology and Bellvitge University Hospital - Department of Internal Medicine and Infectious Diseases
Downloads 30 (1,318,317)

Abstract:

Loading...

Anal cancer screening, MSM living with HIV, Cytology, HPV biomarkers, Cost-effectiveness analysis, Simulation models, High-grade squamous intraepithelial lesions (HSIL), Infra-red coagulation (IRC), Trichloroacetic acid (TCA)

4.

Natural History of Anal HSIL and the Predictive Value of Anal Cytology and HPV Biomarkers for Incidence and Clearance in MSM Living with HIV: A Prospective Cohort Study

Number of pages: 25 Posted: 16 Mar 2026
Ana C. Silva-Klug, Sonia Paytubi, Loris Trenti, Monica Sanchez-Llamas, Nuria Baixeras, Gonzalo Peon, Sara Tous, Miquel Pavon, Montserrat Torres, Silvia De Sanjose, Jaime Vega-Costa, August Vidal, Laia Alemany, Daniel Podzamczer and Maria Saumoy
Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Bellvitge University Hospital, Bellvitge University Hospital, University of Barcelona - Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Gran Via de l'Hospitale, Instituto de Salud Carlos III, Barcelona Institute for Global Health (ISGlobal), University of Barcelona - Bellvitge University Hospital, Bellvitge University Hospital, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Bellvitge University Hospital and Bellvitge University Hospital - Department of Internal Medicine and Infectious Diseases
Downloads 21 (1,436,435)

Abstract:

Loading...

HPV, HIV, HSIL, anal cancer, mRNA testing